Regulatory & Legal

A viral 'vapor rub honey trick' is selling a new supplement. We investigate VapoFil's claims and find a stark gap between marketing and science.

With new policy and global business experts at the helm, the Weinberg Foundation is strategically positioning itself to tackle poverty amid global shifts.

With a $10M offering led by its first customer, HeartBeam is set to commercialize its revolutionary 3D ECG system for remote heart health.

The semiconductor firm shattered its own Q1 forecast, raising guidance as the AI boom fuels unprecedented growth ahead of its May 5 earnings call.

A sweeping new plan aims to transform the 192-acre site into a year-round hub, but faces questions on community access and provincial oversight.

A women's wellness brand is the first to earn a rigorous purity award for its beef organ supplement, setting a new benchmark for transparency and safety.

Surpassing 1,000 verified Trustpilot reviews, Hola Prime challenges industry norms with its radical transparency and a game-changing 1-Hour Payout model.

Las Vegas trial lawyer Robert Eglet's induction into the Trial Lawyer Hall of Fame signals a new era for the city and a legacy of corporate accountability.

The new CMS Medicare App Library is giving millions of seniors access to AI-driven health tools, but can technology bridge the gap in patient care?

Florian Frischmuth, a former Ford software leader, joins Envorso to guide clients through the complex, high-stakes shift to software-defined vehicles.

New data reveals nearly 4 in 10 women lack key vaginal bacteria linked to fertility, sparking a new conversation about an invisible factor in conception.

Verallia's new €63M hybrid furnace in Spain cuts CO2 by over 50%, signaling a major shift in the energy-intensive glass packaging industry.

Medical advances are increasing organ transplants in Quebec, but with nearly 900 people on the waiting list, experts say major systemic reform is essential.

Biopharma veteran Glenn Gormley joins Aktis's board, bringing deep ADC expertise to guide the company's next-gen radiopharmaceutical pipeline.

Allegro MicroSystems' upcoming Q4 results will be a key indicator for the auto and AI chip markets. Investors eye growth amid fierce competition.

Eshallgo Inc. executes a reverse stock split to stay on Nasdaq, but can its AI ambitions overcome deep financial struggles and investor skepticism?

GC Biopharma's new data on ALYGLO's purity profile could set a new standard for IVIG therapies, impacting patient safety in a rapidly growing market.

A new ad campaign attacks hospitals for failing to disclose prices, amplifying a DC battle as HHS Secretary Kennedy faces Congress on healthcare costs.

As Cimpress preps its Q3 results, investors watch to see if record growth can be sustained amid margin pressures in the booming custom print market.

A new ANAB accreditation for OmnexFuturepast aims to bolster trust in vehicle safety and cybersecurity across the entire automotive supply chain.